| Trial ID: | L5823 |
| Source ID: | NCT00254085
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Insulin Aspart
|
| Outcome Measures: |
Primary: Blood glucose fluctuations | Secondary: number of hypoglycemia
|
| Sponsor/Collaborators: |
Sponsor: University Hospital, Gentofte, Copenhagen
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-03
|
| Completion Date: |
2006-03
|
| Results First Posted: |
|
| Last Update Posted: |
2005-11-15
|
| Locations: |
Gentofte University Hospital, Hellerup, 2900, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00254085
|
